Bleomycin Sulfate

CAS 9041-93-4 4 current records 1 historicalPeptide

Who holds supplier records for Bleomycin Sulfate? 4 organisations hold a current record for Bleomycin Sulfate: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Netherlands (1), China (1) and Japan (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Bleomycin Sulfate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/bleomycin-sulfate

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Bleomycin Sulfate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Netherlands1China1Japan1Country not recorded for 1
Need Bleomycin Sulfate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Bleomycin Sulfate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
HUBEI HONCH PHARMACEUTICAL CO., LTD. HuanggangCN
CEP 2025-187 - Rev 00
Bleomycin Sulfate
Sept 2026Inspected Feb 2025
Switzerland
TAPI NL B.V. AmsterdamNL
CEP 2021-272 - Rev 02
Bleomycin Sulfate
Jun 2025—
NIPPON KAYAKU CO., LTD. TokyoJP
CEP 2002-149 - Rev 05
Bleomycin Sulfate
Dec 2023—
Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou CityCN
R1-CEP 2012-197 - Rev 00
Bleomycin Sulfate, Alternative process
May 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Bleomycin Sulfate are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • MAYNE PHARMA USA INC
    Inactive DMF 13254 · filed Oct 1998

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Bleomycin Sulfate is an antineoplastic antibiotic used to treat various types of cancer. It functions by causing breaks in DNA strands, leading to cancer cell apoptosis.

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Cytoprotective Agent

Therapeutic areas

OncologyDermatologyPulmonology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Bleomycin Sulfate?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Bleomycin Sulfate: HUBEI HONCH PHARMACEUTICAL CO LTD, TAPI NL BV (Netherlands), Zhejiang Hisun Pharmaceutical Co., Ltd. (China) and Nippon Kayaku Co., Ltd. (Japan). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Bleomycin Sulfate Drug Master Files are active?

HUBEI HONCH PHARMACEUTICAL CO LTD (DMF 42629), TAPI NL BV (DMF 13784) and Zhejiang Hisun Pharmaceutical Co., Ltd. (DMF 12962, 26312). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Bleomycin Sulfate records mean?

1 organisation has only inactive Type II DMFs for Bleomycin Sulfate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Bleomycin Sulfate have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Bleomycin Sulfate on the EDQM register, including HUBEI HONCH PHARMACEUTICAL CO., LTD. Huanggang (CN), TAPI NL B.V. Amsterdam (NL), NIPPON KAYAKU CO., LTD. Tokyo (JP) and Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Bleomycin Sulfate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Bleomycin Sulfate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.